Breast conservation a good option for non-invasive, 'early' breast cancer, U-M study showsMay 08, 2006Follow-up mammograms reliable for detecting return of cancer ANN ARBOR, Mich. - For women diagnosed with a type of non-invasive breast cancer, removing the breast is not the only treatment option. Breast conserving surgery, long known to be successful at treating the more common invasive cancer, can also be effective for this pre-invasive condition, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center. The condition, called ductal carcinoma in situ, or DCIS, is being diagnosed more often. It accounts for 22 percent of all breast cancer diagnoses and affects about 62,000 women each year. If left untreated, DCIS can progress to invasive breast cancer, which is the most common type of breast cancer diagnosed. Treatment for DCIS is either mastectomy, which removes the entire breast, or breast-conserving lumpectomy, which removes only the cancerous area, followed by radiation therapy. In this study, researchers at U-M and William Beaumont Hospital in Royal Oak, Mich., looked at the records of women who had opted for lumpectomy and radiation for DCIS between 1981 and 2003. Of the 513 women studied, only 8 percent developed a recurrence of breast cancer or DCIS. Of those recurrences, 97 percent were detected by mammography, and 91 percent were diagnosed exclusively by mammography, suggesting that regular follow-up mammograms are a reliable way of detecting any return of cancer after breast-conserving surgery. "Lumpectomy with radiation is an excellent treatment for DCIS. Women should not feel they need to have mastectomy in order to have a good prognosis. If they follow up with regular mammograms, a recurrence can be detected early before it has had a negative effect on prognosis," says study author Renee Pinsky, M.D., assistant professor of radiology at the University of Michigan Medical School. Pinksy presented the findings May 4, 2006, at the American Roentgen Ray Society annual meeting in Vancouver, British Columbia. The majority of recurrences involved another non-invasive cancer. Among those women who did develop invasive breast cancer, two-thirds had tumors smaller than 1 centimeter, which is considered to be small. All recurrences were stage 0 or 1, the least-advanced and most easily treated stages, which are associated with the best prognosis. "Recurrence after DCIS treated with lumpectomy and radiation is rare and easily detected by mammogram. Provided they seek recommended follow-up mammograms, women can feel confident choosing breast conserving surgery with radiation to treat DCIS," Pinsky says. University of Michigan Health System |
|||||||||||||||||||||
| Related Breast Cancer Current Events and Breast Cancer News Articles Menopause-cardiology consensus statement on cardiovascular disease and on HRT A menopause-cardiology consensus statement has called for direct action to prevent cardiovascular disease (CVD) in menopausal women. The statement also concludes that there is little evidence of increased CVD risk in taking HRT. Researchers Identify Role of Gene in Tumor Development, Growth and Progression Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis. UCLA researchers create 'fly paper' to capture circulating cancer cells Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor. Fertility procedures need not delay breast cancer treatment for younger women A new study published in the November issue of the Journal of the American College of Surgeons shows that breast cancer patients under 40 years old who undergo fertility preservation do not face a significant delay in the treatment of their disease when their care is coordinated in a timely fashion. Coffee break: Compound brewing new research in colon, breast cancer A compound in coffee has been found to be estrogenic in studies by Texas AgriLife Research scientists. Drugs to treat anemia in cancer patients linked to thromboembolism Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., co-director of the breast cancer program at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center. Discovery in worms by Queen's researchers points to more targeted cancer treatment Researchers at Queen's University have found a link between two genes involved in cancer formation in humans, by examining the genes in worms. The groundbreaking discovery provides a foundation for how tumor-forming genes interact, and may offer a drug target for cancer treatment. FDA approved leukemia drugs shows promise in ovarian cancer cells The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive Cancer Center found. Carnegie Mellon researchers link health-care debate to risk of dying in US and Europe The current health care debate in the United States is complicated. Trade-offs between heath care expenditures, lifestyle choices and life expectancy have been suggested but seldom clearly demonstrated. Scientists uncover new key to the puzzle of hormone therapy and breast cancer The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer. More Breast Cancer Current Events and Breast Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||